EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit

Immunomagnetic positive selection cell isolation kit

New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit

Immunomagnetic positive selection cell isolation kit

From: 668 USD
Catalog #
(Select a product)
Immunomagnetic positive selection cell isolation kit
Add to Wish List

Product Advantages


  • Fast and easy-to-use

  • Up to 93% purity

  • No columns required

What's Included

  • EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit (Catalog #18782)
    • EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Cocktail, 0.5 mL
    • EasySep™ PE Selection Cocktail, 1 mL
    • EasySep™ Dextran RapidSpheres™ 50100, 1 mL
    • EasySep™ Mouse FcR Blocker, 0.5 mL
  • RoboSep™ Mouse CD25 Regulatory T cell Positive Selection Kit (Catalog #18782RF)
    • EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Cocktail, 0.5 mL
    • EasySep™ PE Selection Cocktail, 1 mL
    • EasySep™ Dextran RapidSpheres™ 50100, 1 mL
    • EasySep™ Mouse FcR Blocker, 0.5 mL
    • RoboSep™ Buffer (Catalog #20104)
    • RoboSep™ Filter Tips (Catalog #20125)
Products for Your Protocol

Overview

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single-cell suspensions of splenocytes or other tissues by positive selection. The kit targets CD25 regulatory T cells for positive selection with a PE-labeled antibody directed against the CD25 surface marker. Desired cells are labeled with antibodies and magnetic particles. The cells are separated without columns using an EasySep™ magnet. Unwanted cells are simply poured off, while desired cells remain in the tube.
Magnet Compatibility
• EasySep™ Magnet (Catalog #18000)
• “The Big Easy” EasySep™ Magnet (Catalog #18001)
• EasyEights™ Magnet (Catalog #18103)
• RoboSep™-S (Catalog #21000)
Subtype
Cell Isolation Kits
Cell Type
T Cells, T Cells, CD4+, T Cells, Regulatory
Species
Mouse
Sample Source
Other, Spleen
Selection Method
Positive
Application
Cell Isolation
Brand
EasySep, RoboSep
Area of Interest
Immunology

Data Figures

Typical EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Profile

Figure 1. Typical EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Profile

Starting with mouse splenocytes, the CD25 regulatory T cell content (CD4+CD25+FOXP3+) of the isolated fraction typically ranges from 80 - 93%. In the example above, the final purities of the start and isolated fractions are 2.1% and 87.5%, respectively.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
18782
Lot #
All
Language
English
Catalog #
18782RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
18782
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
18782
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
18782
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
18782
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
18782RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
18782RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
18782RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
18782RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 5
Catalog #
18782RF
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Publications (2)

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis. R. F. Porter et al. Molecules (Basel, Switzerland) 2019 sep

Abstract

(1) Background: The cannabinoid 2 receptor (CB2R) is a promising anti-inflammatory drug target and development of selective CB2R ligands may be useful for treating sight-threatening ocular inflammation. (2) Methods: This study examined the pharmacology of three novel chemically-diverse selective CB2R ligands: CB2R agonists, RO6871304, and RO6871085, as well as a CB2R inverse agonist, RO6851228. In silico molecular modelling and in vitro cell-based receptor assays were used to verify CB2R interactions, binding, cell signaling ({\ss}-arrestin and cAMP) and early absorption, distribution, metabolism, excretion, and toxicology (ADMET) profiling of these receptor ligands. All ligands were evaluated for their efficacy to modulate leukocyte-neutrophil activity, in comparison to the reported CB2R ligand, HU910, using an in vivo mouse model of endotoxin-induced uveitis (EIU) in wild-type (WT) and CB2R-/- mice. The actions of RO6871304 on neutrophil migration and adhesion were examined in vitro using isolated neutrophils from WT and CB2R-/- mice, and in vivo in WT mice with EIU using adoptive transfer of WT and CB2R-/- neutrophils, respectively. (3) Results: Molecular docking studies indicated that RO6871304 and RO6871085 bind to the orthosteric site of CB2R. Binding studies and cell signaling assays for RO6871304 and RO6871085 confirmed high-affinity binding to CB2R and selectivity for CB2R {\textgreater} CB1R, with both ligands acting as full agonists in cAMP and {\ss}-arrestin assays (EC50s in low nM range). When tested in EIU, topical application of RO6871304 and RO6871085 decreased leukocyte-endothelial adhesion and this effect was antagonized by the inverse agonist, RO6851228. The CB2R agonist, RO6871304, decreased in vitro neutrophil migration of WT neutrophils but not neutrophils from CB2R-/-, and attenuated adhesion of adoptively-transferred leukocytes in EIU. (4) Conclusions: These unique ligands are potent and selective for CB2R and have good immunomodulating actions in the eye. RO6871304 and RO6871085, as well as HU910, decreased leukocyte adhesion in EIU through inhibition of resident ocular immune cells. The data generated with these three structurally-diverse and highly-selective CB2R agonists support selective targeting of CB2R for treating ocular inflammatory diseases.
Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity. Kieback E et al. Immunity 2016 MAY

Abstract

Regulatory T (Treg) cells expressing Foxp3 transcripton factor are essential for immune homeostasis. They arise in the thymus as a separate lineage from conventional CD4(+)Foxp3(-) T (Tconv) cells. Here, we show that the thymic development of Treg cells depends on the expression of their endogenous cognate self-antigen. The formation of these cells was impaired in mice lacking this self-antigen, while Tconv cell development was not negatively affected. Thymus-derived Treg cells were selected by self-antigens in a specific manner, while autoreactive Tconv cells were produced through degenerate recognition of distinct antigens. These distinct modes of development were associated with the expression of T cell receptor of higher functional avidity for self-antigen by Treg cells than Tconv cells, a difference subsequently essential for the control of autoimmunity. Our study documents how self-antigens define the repertoire of thymus-derived Treg cells to subsequently endow this cell type with the capacity to undermine autoimmune attack.
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more